Oil Prices Rise as Iran Holds Firm on Strait of Hormuz Deal 
Samsung Invests $1 Billion in KKR’s Helix AI Infrastructure 
U.S. Stock Futures Fall as Iran, Oil and AI Risks Rattle Markets 
UK Housebuilder Stocks Surge on New First-Time Buyer Loan Scheme 
Goldman Sachs Eyes John Waldron as CEO Successor 
Nvidia China Chip Sales Report Sends Chinese Semiconductor Stocks Lower 
TSMC Accelerates 2nm Expansion as AI Chip Demand Surges 
Oil Surge Pressures Global Stocks as U.S.-Iran Truce Hopes Fade 
Pi Network Price Holds $0.087 as Protocol 28 Mainnet Upgrade Nears 
China, US Extend Trade Truce Through January 10 After Trump-Xi Summit 
Anthropic Targets $2 Trillion Valuation in Planned IPO 
RedotPay Completes Audits as Stablecoin Firm Advances U.S. IPO Plans 
Toyota Global Sales Fall for Seventh Month as China Demand Slumps 
RBA Set for September Rate Hike as Inflation Stays High 
Asian Currencies Mixed as Yen Weakens, RBA Hike Looms 
Asian Currencies Weaken as Dollar, Oil Prices Rise 
RBA Hikes Interest Rate to 4.60% as Inflation Risks Rise 
Add as a preferred source on Google
Lotte Biologics is reportedly accused of stealing the trade secrets of its rival, Samsung Biologics. A probe into the case was already launched by prosecutors, and officials will be especially checking into some of the company’s employees who were suspected of the crime.
According to The Korea Times, the Incheon District Prosecutors' Office dispatched investigators last week to search the headquarters of Lotte Biologics located in Seoul’s Lotte World Tower. The raid took place on Friday, Oct. 7, and during the search, authorities said they were able to secure the computers of three former workers who were revealed to have moved from Samsung Biologics to Lotte Biologics, but their job positions in the company were not revealed.
Prior to the investigation, it was reported that Samsung Biologics filed to apply for a court directive for the infringement of its company trade secrets in May. In the application for the injunction, it mentioned its three former employees who moved to Lotte Biologics in July.
While their job roles were not disclosed, the three people were said to have work duties related to Samsung Biologics’ core business. The trio was also said to have printed a large number of company documents before transferring to its rival firm, Lotte Biologics.
The Incheon District Court responded to the application by granting Lotte’s request and issuing an injunction against the infringement of trade secrets that were filed by Samsung’s biotechnology business unit on July 29. The directive was to prevent the leak of any business secrets that could be utilized by Lotte Biologics for its benefit.
"We cannot reveal the specifics of the investigation including the search and seizure," the prosecution body commented with regard to the recent raid at the Lotte Biologics HQ
Meanwhile, the biological CDMO (Contract Development Manufacturing Organization) division of the Lotte Group was said to have started hiring bio professionals in the last quarter of 2021 as it was preparing to jump into the bio business. Based on the reports, many of the new hires were recruited from Samsung Biologics.
